Federal Supply Schedule 36F79724D0187

Sentynl Therapeutics, Inc. has been awarded a multiple-award Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) master contract to supply pharmaceutical and hematology-related products to the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs. The contract was awarded on September 1, 2024, with a ceiling value of $250,000.00 and an ultimate completion date of August 31, 2029. This five-year contract represents a non-set-aside competitive procurement within the established General Services Administration schedule framework, enabling the VA to procure pharmaceutical products on an indefinite-delivery basis through task orders or purchase orders as needed.

The contract scope encompasses Federal Supply Classification 65 I B products, which include drugs, pharmaceuticals, and hematology-related items. Notably, the contract includes a product deletion for one National Drug Code (73079-0075-30) associated with ZOKINVY, indicating that this specific pharmaceutical product has been removed from the available offerings under this contract. As a Federal Supply Schedule contract, this vehicle provides VISN 12 with pre-negotiated pricing and terms, streamlining the procurement process for pharmaceutical supplies while maintaining competition through the multiple-award structure.